10-Q Filing

ENVERIC BIOSCIENCES, INC. CIK: 890821 Q3 2021

Filing Information

Form Type	10-Q
Accession Number	`0001493152-21-028263`
Period End Date	20210930
Filing Date	20211115
Fiscal Year	2021
Fiscal Period	Q3
XBRL Instance	form10-q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 64 Income Statement 63 Cash Flow Statement 88 Stockholders Equity 58

Balance Sheet 64 line items

Line Item	Tag	Value	Unit	Period
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	-	USD	Point-in-time
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$2.24K	USD	Point-in-time
Finite-Lived Intangible Assets, Accumulated Amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$126.97K	USD	Point-in-time
Finite-Lived Intangible Assets, Accumulated Amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$592.70K	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash	`Cash`	$21.45M	USD	Point-in-time
Cash	`Cash`	$1.58M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$833.12K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$700.71K	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$22.28M	USD	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	3.28M	shares	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$2.28M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesOutstanding`	3.28M	shares	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Fixed assets, net of accumulated depreciation of $2,240 and $-0- as of September 30, 2021 and December 31, 2020, respectively	`PropertyPlantAndEquipmentNet`	-	USD	Point-in-time
Fixed assets, net of accumulated depreciation of $2,240 and $-0- as of September 30, 2021 and December 31, 2020, respectively	`PropertyPlantAndEquipmentNet`	$140.57K	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Intangible assets, net of accumulated amortization of $592,700 and $126,968 as of September 30, 2021 and December 31, 2020, respectively	`FiniteLivedIntangibleAssetsNet`	$38.27M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Intangible assets, net of accumulated amortization of $592,700 and $126,968 as of September 30, 2021 and December 31, 2020, respectively	`FiniteLivedIntangibleAssetsNet`	$1.82M	USD	Point-in-time
Goodwill	`Goodwill`	$9.06M	USD	Point-in-time
Goodwill	`Goodwill`	-	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	31.38M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	10.10M	shares	Point-in-time
Total assets	`Assets`	$69.76M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	31.38M	shares	Point-in-time
Total assets	`Assets`	$4.10M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	10.10M	shares	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent`	$681.25K	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent`	$2.16M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.16M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$681.25K	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiability`	$9.06M	USD	Point-in-time
Warrant liability	`WarrantLiabilitiesNoncurrent`	$3.17M	USD	Point-in-time
Warrant liability	`WarrantLiabilitiesNoncurrent`	-	USD	Point-in-time
Total liabilities	`Liabilities`	$681.25K	USD	Point-in-time
Total liabilities	`Liabilities`	$14.39M	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred Stock, $0.01 par value, 20,000,000 shares authorized, 0 and 3,275,407 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively	`PreferredStockValue`	-	USD	Point-in-time
Preferred Stock, $0.01 par value, 20,000,000 shares authorized, 0 and 3,275,407 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively	`PreferredStockValue`	$32.75K	USD	Point-in-time
Common stock, $0.01 par value, 100,000,000 shares authorized, 31,383,632 and 10,095,109 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$100.95K	USD	Point-in-time
Common stock, $0.01 par value, 100,000,000 shares authorized, 31,383,632 and 10,095,109 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$313.84K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$15.22M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$73.87M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-11.76M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-18.63M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-181.28K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-185.31K	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$-2.70M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$-3.48M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$18.99M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$-1.81M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$55.37M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$-3.59M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$18.82M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$3.42M	USD	Point-in-time
Total Liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$69.76M	USD	Point-in-time
Total Liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$4.10M	USD	Point-in-time

Income Statement 63 line items

Line Item	Tag	Value	Unit	Period
Research and development costs	`ResearchAndDevelopmentExpense`	$2.30M	USD	3 Qtrs
Research and development costs	`ResearchAndDevelopmentExpense`	$134.26K	USD	3 Qtrs
Research and development costs	`ResearchAndDevelopmentExpense`	$63.30K	USD	1 Quarter
Research and development costs	`ResearchAndDevelopmentExpense`	$1.22M	USD	1 Quarter
General and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$2.12M	USD	1 Quarter
General and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$1.96M	USD	3 Qtrs
General and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$10.86M	USD	3 Qtrs
General and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$426.53K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	-	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$484.36K	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$173.70K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	-	USD	3 Qtrs
Total operating expenses	`OperatingCostsAndExpenses`	$3.52M	USD	1 Quarter
Total operating expenses	`OperatingCostsAndExpenses`	$489.83K	USD	1 Quarter
Total operating expenses	`OperatingCostsAndExpenses`	$13.64M	USD	3 Qtrs
Total operating expenses	`OperatingCostsAndExpenses`	$2.09M	USD	3 Qtrs
Loss from Operations	`OperatingIncomeLoss`	$-13.64M	USD	3 Qtrs
Loss from Operations	`OperatingIncomeLoss`	$-2.09M	USD	3 Qtrs
Loss from Operations	`OperatingIncomeLoss`	$-3.52M	USD	1 Quarter
Loss from Operations	`OperatingIncomeLoss`	$-489.83K	USD	1 Quarter
Interest expense	`InterestExpense`	$5.19K	USD	3 Qtrs
Interest expense	`InterestExpense`	$370.00	USD	1 Quarter
Interest expense	`InterestExpense`	$75.50K	USD	1 Quarter
Interest expense	`InterestExpense`	$388.14K	USD	3 Qtrs
Change in fair value of warrant liabilities	`FairValueAdjustmentOfWarrants`	$-7.08M	USD	3 Qtrs
Change in fair value of warrant liabilities	`FairValueAdjustmentOfWarrants`	$-804.83K	USD	1 Quarter
Change in fair value of warrant liabilities	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Change in fair value of warrant liabilities	`FairValueAdjustmentOfWarrants`	-	USD	3 Qtrs
Inducement expense	`InducementExpense`	-	USD	1 Quarter
Inducement expense	`InducementExpense`	-	USD	1 Quarter
Inducement expense	`InducementExpense`	$298.71K	USD	3 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$804.46K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-388.14K	USD	3 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$-75.50K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$6.77M	USD	3 Qtrs
Net Loss	`NetIncomeLoss`	$-3.25M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-908.29K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-565.34K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-1.10M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-2.71M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-2.48M	USD	3 Qtrs
Net Loss	`NetIncomeLoss`	$-818.39K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-6.87M	USD	3 Qtrs
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-4.04K	USD	3 Qtrs
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-12.70K	USD	1 Quarter
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-10.07K	USD	1 Quarter
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-6.51K	USD	1 Quarter
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-33.26K	USD	1 Quarter
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$35.74K	USD	1 Quarter
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-30.08K	USD	3 Qtrs
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-7.31K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-6.88M	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-2.51M	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-572.64K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-2.72M	USD	1 Quarter
Net loss per share basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.10	USD	1 Quarter
Net loss per share basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.12	USD	1 Quarter
Net loss per share basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.43	USD	3 Qtrs
Net loss per share basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.34	USD	3 Qtrs
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	23.14M	shares	1 Quarter
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	20.33M	shares	3 Qtrs
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	5.86M	shares	1 Quarter
Weighted average shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	5.73M	shares	3 Qtrs

Cash Flow Statement 88 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-3.25M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-908.29K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-565.34K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.10M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.71M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.48M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-818.39K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.87M	USD	3 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	-	USD	3 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$285.86K	USD	3 Qtrs
Accrued interest	`AccruedInterest`	$102.28K	USD	3 Qtrs
Accrued interest	`AccruedInterest`	-	USD	3 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-7.08M	USD	3 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-804.83K	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	-	USD	3 Qtrs
Stock and option based compensation	`ShareBasedCompensation`	-	USD	3 Qtrs
Stock and option based compensation	`ShareBasedCompensation`	$4.83M	USD	3 Qtrs
Inducement expense	`GainsLossesOnInducementExpense`	$-298.71K	USD	3 Qtrs
Inducement expense	`GainsLossesOnInducementExpense`	-	USD	3 Qtrs
Depreciation and amortization expense	`DepreciationAndAmortization`	-	USD	1 Quarter
Depreciation and amortization expense	`DepreciationAndAmortization`	$484.36K	USD	3 Qtrs
Depreciation and amortization expense	`DepreciationAndAmortization`	$173.70K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationAndAmortization`	-	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.84K	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-320.12K	USD	3 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndOtherCurrentLiabilities`	$625.75K	USD	3 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndOtherCurrentLiabilities`	$522.16K	USD	3 Qtrs
Due from related party	`IncreaseDecreaseInDueFromRelatedParties`	-	USD	3 Qtrs
Due from related party	`IncreaseDecreaseInDueFromRelatedParties`	$65.08K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.64M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-7.39M	USD	3 Qtrs
Purchase of Diverse Bio license agreement	`PaymentsToAcquireIntangibleAssets`	-	USD	3 Qtrs
Purchase of Diverse Bio license agreement	`PaymentsToAcquireIntangibleAssets`	$675.00K	USD	3 Qtrs
Cash accretive acquisition of MagicMed	`ProceedsFromAmalgamationAgreement`	-	USD	3 Qtrs
Cash accretive acquisition of MagicMed	`ProceedsFromAmalgamationAgreement`	$3.06M	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$2.38M	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	3 Qtrs
Proceeds from sale of common stock and warrants, net of offering costs	`ProceedsFromIssuanceOfCommonStock`	$21.61M	USD	3 Qtrs
Proceeds from sale of common stock and warrants, net of offering costs	`ProceedsFromIssuanceOfCommonStock`	$227.50K	USD	3 Qtrs
Proceeds from convertible notes payable	`ProceedsFromConvertibleDebt`	-	USD	3 Qtrs
Proceeds from convertible notes payable	`ProceedsFromConvertibleDebt`	$50.00K	USD	3 Qtrs
Proceeds from note payable	`ProceedsFromNotesPayable`	-	USD	3 Qtrs
Proceeds from note payable	`ProceedsFromNotesPayable`	$1.81M	USD	3 Qtrs
Repayment of note payable	`RepaymentsOfNotesPayable`	-	USD	3 Qtrs
Repayment of note payable	`RepaymentsOfNotesPayable`	$157.71K	USD	3 Qtrs
Proceeds from warrant exercises, net of fees	`ProceedsFromWarrantExercises`	-	USD	3 Qtrs
Proceeds from warrant exercises, net of fees	`ProceedsFromWarrantExercises`	$3.29M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$24.90M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.93M	USD	3 Qtrs
Effect of foreign exchange rate on cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$3.79K	USD	3 Qtrs
Effect of foreign exchange rate on cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$-19.66K	USD	3 Qtrs
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$19.87M	USD	3 Qtrs
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$297.18K	USD	3 Qtrs
Cash - Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$21.45M	USD	Point-in-time
Cash - Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.58M	USD	Point-in-time
Cash - Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$340.90K	USD	Point-in-time
Cash - Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$43.71K	USD	Point-in-time
Cash - End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$21.45M	USD	Point-in-time
Cash - End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.58M	USD	Point-in-time
Cash - End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$340.90K	USD	Point-in-time
Cash - End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$43.71K	USD	Point-in-time
Issuance of Common Stock pursuant to MagicMed amalgamation	`IssuanceOfCommonStockPursuantToAmalgamation`	$39.04M	USD	3 Qtrs
Issuance of Common Stock pursuant to MagicMed amalgamation	`IssuanceOfCommonStockPursuantToAmalgamation`	-	USD	3 Qtrs
Deferred tax liability incurred due to MagicMed amalgamation	`DeferredTaxLiabilityIncurredDueToAmalgamation`	$9.06M	USD	3 Qtrs
Deferred tax liability incurred due to MagicMed amalgamation	`DeferredTaxLiabilityIncurredDueToAmalgamation`	-	USD	3 Qtrs
Conversion of preferred stock to common stock$	`ConversionOfPreferredStockToCommonStock`	$32.75K	USD	3 Qtrs
Conversion of preferred stock to common stock$	`ConversionOfPreferredStockToCommonStock`	-	USD	3 Qtrs
Fair value of warrants issued	`FairValueOfWarrantsIssued`	-	USD	3 Qtrs
Fair value of warrants issued	`FairValueOfWarrantsIssued`	$9.98M	USD	3 Qtrs
Fair value of Ameri warrants	`FairValueOfWarrants`	$262.49K	USD	3 Qtrs
Fair value of Ameri warrants	`FairValueOfWarrants`	-	USD	3 Qtrs
Beneficial conversion feature issued with note payable	`BeneficialConversionFeatureIssuedWithNotePayable`	-	USD	3 Qtrs
Beneficial conversion feature issued with note payable	`BeneficialConversionFeatureIssuedWithNotePayable`	$17.85K	USD	3 Qtrs
Warrants issued in conjunction with notes payable issuances	`WarrantsIssuedInConjunctionWithNotesPayable`	-	USD	3 Qtrs
Warrants issued in conjunction with notes payable issuances	`WarrantsIssuedInConjunctionWithNotesPayable`	$32.15K	USD	3 Qtrs
Common stock issued for accounts payable	`StockIssuedDuringPeriodValueCommonStockIssuedForAccountsPayable`	$173.48K	USD	3 Qtrs
Common stock issued for accounts payable	`StockIssuedDuringPeriodValueCommonStockIssuedForAccountsPayable`	-	USD	3 Qtrs
Common stock issued for accounts payable	`StockIssuedDuringPeriodValueCommonStockIssuedForAccountsPayable`	$173.48K	USD	1 Quarter
Common stock issued in conjunction with note payable modification	`StockIssuedDuringPeriodValueCommonStockIssuedInConjunctionWithNotPayableModification`	$45.73K	USD	3 Qtrs
Common stock issued in conjunction with note payable modification	`StockIssuedDuringPeriodValueCommonStockIssuedInConjunctionWithNotPayableModification`	$45.73K	USD	1 Quarter
Common stock issued in conjunction with note payable modification	`StockIssuedDuringPeriodValueCommonStockIssuedInConjunctionWithNotPayableModification`	-	USD	3 Qtrs
Conversion of related party advances and notes payable into common stock	`ConversionOfRelatedPartyAdvancesAndNotesPayableIntoCommonStock`	$238.00K	USD	3 Qtrs
Conversion of related party advances and notes payable into common stock	`ConversionOfRelatedPartyAdvancesAndNotesPayableIntoCommonStock`	-	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$388.14K	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$5.19K	USD	3 Qtrs
Cash paid for income taxes	`IncomeTaxesPaidNet`	-	USD	3 Qtrs
Cash paid for income taxes	`IncomeTaxesPaidNet`	-	USD	3 Qtrs

Stockholders Equity 58 line items

Line Item	Tag	Value	Unit	Period
Beginning balance, value	`StockholdersEquity`	$-2.70M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$-3.48M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$18.99M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$-1.81M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$55.37M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$-3.59M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$18.82M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$3.42M	USD	Point-in-time
Common stock issued for accounts payable	`StockIssuedDuringPeriodValueCommonStockIssuedForAccountsPayable`	$173.48K	USD	3 Qtrs
Common stock issued for accounts payable	`StockIssuedDuringPeriodValueCommonStockIssuedForAccountsPayable`	-	USD	3 Qtrs
Common stock issued for accounts payable	`StockIssuedDuringPeriodValueCommonStockIssuedForAccountsPayable`	$173.48K	USD	1 Quarter
Warrants issued in conjunction with notes payable	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$32.15K	USD	1 Quarter
Beneficial conversion feature issued with note payable	`AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature`	$17.85K	USD	1 Quarter
Consideration paid pursuant to amalgamation agreement	`ConsiderationPaidPursuantToAmalgamationAgreement`	$39.04M	USD	1 Quarter
Stock based compensation	`AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet`	$717.47K	USD	1 Quarter
Stock based compensation	`AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet`	$486.99K	USD	1 Quarter
Stock based compensation	`AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet`	$3.59M	USD	1 Quarter
Reserve for Ameri warrant liabilities	`ReserveForAmeriWarrantLiabilities`	$-262.49K	USD	1 Quarter
Induced conversion of stock options into restricted stock awards	`AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium`	$298.71K	USD	1 Quarter
Conversion of Series B Preferred Stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	-	USD	1 Quarter
Conversion of stock options into restricted stock	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	1 Quarter
Conversion of stock options into restricted stock	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$6.97M	USD	3 Qtrs
Exercise of warrants	`ExerciseOfWarrants`	$17.93K	USD	1 Quarter
Exercise of options	`StockIssuedDuringPeriodValueStockOptionsExercised`	-	USD	1 Quarter
Exercise of options, shares	`StockIssuedDuringPeriodSharesStockOptionsExercised`	143,796.00	shares	3 Qtrs
Stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$33.47K	USD	1 Quarter
Foreign exchange loss	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-4.04K	USD	3 Qtrs
Foreign exchange loss	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-12.70K	USD	1 Quarter
Foreign exchange loss	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-10.07K	USD	1 Quarter
Foreign exchange loss	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-6.51K	USD	1 Quarter
Foreign exchange loss	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-33.26K	USD	1 Quarter
Foreign exchange loss	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$35.74K	USD	1 Quarter
Foreign exchange loss	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-30.08K	USD	3 Qtrs
Foreign exchange loss	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-7.31K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.25M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-908.29K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-565.34K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.10M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.71M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.48M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-818.39K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.87M	USD	3 Qtrs
Common stock issued in conjunction with note payable modification	`StockIssuedDuringPeriodValueCommonStockIssuedInConjunctionWithNotPayableModification`	$45.73K	USD	3 Qtrs
Common stock issued in conjunction with note payable modification	`StockIssuedDuringPeriodValueCommonStockIssuedInConjunctionWithNotPayableModification`	$45.73K	USD	1 Quarter
Common stock issued in conjunction with note payable modification	`StockIssuedDuringPeriodValueCommonStockIssuedInConjunctionWithNotPayableModification`	-	USD	3 Qtrs
Private equity placement	`PrivateEquityPlacement`	$227.50K	USD	1 Quarter
Conversion of related party advance and notes payable	`ConversionOfRelatedPartyAdvanceAndNotesPayable`	$238.00K	USD	1 Quarter
Ending balance, value	`StockholdersEquity`	$-2.70M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$-3.48M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$18.99M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$-1.81M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$55.37M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$-3.59M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$18.82M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$3.42M	USD	Point-in-time
January 2021 registered direct offering, net	`StockIssuedDuringPeriodValueIssuedDirectOfferingNet`	$4.62M	USD	1 Quarter
February 2021 registered direct offering , net	`StockIssuedDuringPeriodValueIssuedDirectOfferingNetOne`	$7.02M	USD	1 Quarter
Exercise of warrants, net	`ExerciseOfWarrantsNet`	$3.27M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.